Targeted killing of cancer stem cells
Published in The Hindu on August 14, 2009 Cancer treatment has got a shot in the arm. Scientists have been
Read MoreEditorial: A worthwhile programme
Published in The Hindu on December 31, 2009 The National Biomass Cookstove Initiative launched recently will for the first time
Read More
H1N1 pandemic vaccine is safe
The recent announcement by the World Health Organisation that no serious and unexpected adverse effects have been seen in the
Read MoreClimate change science complex, effects clear
Published in The Hindu on December 10, 2009 The surface temperature of Venus is around 460 degree C. In the
Read MoreEditorial: Limiting salt intake
The association between excess salt (sodium) intake and raised blood pressure is well established. According to the World Health Organisation,
Read MoreEditorial: HIV entry ban repealed
Published in The Hindu on November 30, 2009 By announcing the end of a 22-year-old ban on the entry of
Read More‘I absolutely believe that scientists should be paid more than they are currently’
Published in The Hindu on November 26, 2009 If Dr. Venkataraman Ramakrishnan, who shared the Nobel Prize for Chemistry this
Read MoreEditorial: Make pictures speak
Published in the Hindu on November 19, 2009 If the objective is to persuade tobacco users to quit the self-destructive
Read MoreEditorial: Setback to science
Published in The Hindu on November 9, 2009 The career of the disgraced South Korean stem cell researcher, Hwang Woo
Read More
Hyping up science
When a two-decade-long search for an effective vaccine to prevent HIV infection has been a failure, the pressure to hype
Read MoreMeasles: two-dose regimen a must
Published in The Hindu on November 5, 2009 India has failed in controlling measles, an infection that afflicts children. According
Read MoreHwang Woo Suk – down but not out
After becoming the pride of South Korea and gaining worldwide fame due to his `seminal’ work on human embryonic stem
Read More
Conflict of interest in research
With research being funded more and more by the pharmaceutical industry and incentives in the form of shares or cash
Read More